Intraosseous infusion of prostaglandin E2 prevents disuse-induced bone loss in the tibia

Journal of Orthopaedic Research

Volumn 14, Issue 2, 1996, Pages 303-310

  Welch, R D ^a   Ashman, R B ^a   Baker, K J ^a   Browne, R H ^a  

^a TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMECHANICS; BONE; COMPOSITION EFFECTS; DRUG INFUSION; LIVING SYSTEMS STUDIES; LOADS (FORCES); PATIENT TREATMENT; PHYSIOLOGICAL MODELS; STRENGTH OF MATERIALS;

DISUSE INDUCED BONE LOSS; INTRAOSSEOUS INFUSION; PROSTAGLANDIN E;

DRUG THERAPY;

PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE MASS; CONTROLLED STUDY; GOAT; MALE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; TIBIA; WEIGHT BEARING;

EID: 0030111080     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.1100140220     Document Type: Article

References (38)

1. 1 Akamine T, Jee WSS, Ke HZ, Li XJ, Lin BY: Prostaglandin E 2 prevents bone loss and adds extra bone to immobilized distal femoral metaphysis in female rats. Bone 13: 11–22, 1992
2. 2 Ashman RB, Cowin SC, van Buskirk WC, Rice JC: A continuous wave technique for the measurement of the elastic properties of cortical bone. J Biomech 17: 349–361, 1984
3. 3 Ashman RB, Corin JD, Turner CH: Elastic properties of cancellous bone: measurement by an ultrasonic technique. J Biomech 20: 976–986, 1987
4. 4 Binderman I, Shimshoni Z, Somjen D: Biochemical pathways involved in the translation of physical stimulus into biological message. Calcif Tissue Int 36 (Suppl 1): S82–85, 1984
5. 5 Burkhart JM, Jowsey J: Parathyroid and thyroid hormones in the development of immobilization osteoporosis. Endocrinology 81: 1053–1062, 1967
6. 6 Christel P, Cerf C, Pilla A: Time evolution of the mechanical properties of the callus of fresh fractures. Ann Biomed Eng 9: 383–391, 1981
7. 7 Frost HM: Mechanical determinants of bone modeling. Metab Bone Dis 4: 217–229, 1983
8. 8 Frost HM: The pathomechanics of osteoporoses. Clin Orthop 200: 198–225, 1985
9. 9 Garland DE, Stewart CA, Adkins RH, Hu SS, Rosen C, Liotta FJ, Weinstein DA: Osteoporosis after spinal cord injury. J Orthop Res 10: 371–378, 1992
10. 10 High WB: Effects of orally administered prostaglandin E‐2 on cortical bone turnover in adult dogs: a histomorphometric study. Bone 8: 363–373, 1987
11. 11 Jaworski ZFG, Uhthoff HK: Reversibility of nontraumatic disuse osteoporosis during its active phase. Bone 7: 431–439, 1986
12. 12 Jee WSS, Ueno K, Deng YP, Woodbury DM: The effects of prostaglandin E 2 in growing rats: increased metaphyseal hard tissue and cortico‐endosteal bone formation. Calcif Tissue Int 37: 148–157, 1985
13. 13 Jee WSS, Akamine T, Ke HZ, Li XJ, Tang LY, Zeng QQ: Prostaglandin E 2 prevents disuse‐induced cortical bone loss. Bone 13: 153–159, 1992
14. 14 Lauritzen DB, Balena R, Shea M, Seedor JG, Markatos A, Le HM, Toolan BC, Myers ER, Rodan GA, Hayes WC: Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats. J Bone Miner Res 8: 871–879, 1993
15. 15 Li XJ, Jee WSS, Li YL, Patterson‐Buckendahl R: Transient effects of subcutaneously administered prostaglandin E 2 on cancellous and cortical bone in young adult dogs. Bone 11: 353–364, 1990
16. 16 Li M, Jee WSS, Ke HZ, Liang XG, Lin BY, Ma YF, Setterberg RB: Prostaglandin E 2 restores cancellous bone to immobilized limb and adds bone to overloaded limb in right hindlimb immobilization rats. Bone 14: 283–288, 1993
17. 17 Lund JE, Brown WP, Tregerman L: The toxicology of PGE 2. In: Prostaglandins in Medicine: Cardiovascular and Thrombotic Disorders, pp 93–109. Ed by KK Wu and EC Rossi. New York, Yearbook Medical Publishers, 1982
18. 18 Maeda H, Kimmel DB, Raab DM, Lane NE: Musculoskeletal recovery following hindlimb immobilization in adult female rats. Bone 14: 153–159, 1993
19. 19 Mattsson S: The reversibility of disuse osteoporosis: experimental studies in the adult rat. Acta Orthop Scand Suppl 144: 11–12, 1972
20. 20 Miller SC, Marks SC Jr: Effects of prostaglandins on the skeleton. Clin Plast Surg 21: 393–400, 1994
21. 21 Mori S, Jee WSS, Li XJ, Chan S, Kimmel DB: Effects of prostaglandin E 2 on production of new cancellous bone in the axial skeleton of ovariectomized rats. Bone 11: 103–113, 1990
22. 22 Norrdin RW, Jee WSS, High HB: The role of prostaglandins in bone in vivo. Prostaglandins Leukot Essent Fatty Acids 41: 139–149, 1990
23. 23 Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR: Bone histomorphometry: standardization of nomenclature, symbols, and units: report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2: 595–610, 1987
24. 24 Rubin CT, Lanyon LE: Regulation of bone mass by mechanical strain magnitude. Calcif Tissue Int 37: 411–417, 1985
25. 25 Schaffler MB, Pan HQ: Bone cell kinetics in the adult canine skeleton during immobilization. Trans Orthop Res Soc 18: 633, 1993
26. 26 Somjen D, Binderman I, Berger E, Harell A: Bone remodeling induced by physical stress is prostaglandin E 2 mediated. Biochim Biophys Acta 629: 91–100, 1980
27. 27 Thompson DD, Rodan GA: Indomethacin inhibition of tenotomy‐induced bone resorption in rats. J Bone Miner Res 3: 409–414, 1988
28. 28 Tuukkanen J, Wallmark B, Jalovaara P, Takala T, Sjogren S, Vaananen K: Changes induced in growing rat bone by immobilization and remobilization. Bone 12: 113–118, 1991
29. 29 Ueda K, Saito A, Nakano H, Aoshima M, Yokota M, Muraoka R, Iwaya T: Cortical hyperostosis following long‐term administration of prostaglandin E 1 in infants with cyanotic congenital heart disease. J Pediatr 97: 834–836, 1980
30. 30 Uhthoff HK, Jaworski ZFG: Bone loss in response to longterm immobilization. J Bone Joint Surg [Br] 60: 420–429, 1978
31. 31 Waters DJ, Caywood DD, Trachte GJ, Turner RT, Hodgson SF: Immobilization increases bone prostaglandin E: effect of acetylsalicylic acid on disuse osteoporosis studied in dogs. Acta Orthop Scand 62: 238–243, 1991
32. 32 Welch RD, Waldron MJ, Hulse DA, Johnston CE II, Hargis BM: Intraosseous infusion using the Osteoport implant in the caprine tibia. J Orthop Res 10: 789–799, 1992
33. 33 Welch RD, Johnston CE II, Waldron MJ, Poteet B: Intraosseous infusion of prostaglandin E 2 in the caprine tibia. J Orthop Res 11: 110–121, 1993
34. 34 White AA III, Panjabi MM, Southwick WO: The four biomechanical stages of fracture repair. J Bone Joint Surg [Am] 59: 188–192, 1977
35. 35 Wronski TJ, Morey ER: Inhibition of cortical and trabecular bone formation in the long bones of immobilized monkeys. Clin Orthop 181: 269–276, 1983
36. 36 Yang RS, Lui TK, Lin‐Shiau SY: Increased bone growth by local prostaglandin E 2 in rats. Calcif Tissue Int 52: 57–61, 1993
37. 37 Young DR, Niklowitz WJ, Steele CR: Tibial changes in experimental disuse osteoporosis in the monkey. Calcif Tissue Int 35: 304–308, 1983
38. 38 Young DR, Niklowitz WJ, Brown RJ, Jee WSS: Immobilization‐associated osteoporosis in primates. Bone 7: 109–117, 1986